Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Gorboulev et al., 2012)
The pharma companies selling the branded drugs, Novo Nordisk and Eli Lilly, have started offering their treatments at lower prices of around $350 to $700 a month, but thats still unaffordable to many patients who were getting compounded drugs at about $200 a month
OGDH catalyzes the conversion of 2-oxoglutarate (-ketoglutarate) to succinyl-CoA in the TCA cycle
Potential Research Applications: Myostatin inhibition and muscle cell development studies Cellular growth signaling and tissue modeling research Regenerative biology and recovery mechanism investigations Endocrine pathway and growth factor interaction studies For laboratory research only
Baviera, A
US$ 21.95
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 26.78
US$ 21.10
US$ 21.75
US$ 23.90
